Clinical and translational studies support this association, showing that systemic inflammation, characterized by elevated TNF-α, IL-6, and IL-10, along with altered immune checkpoints such as PD-1, is highly prevalent in HF and atrial fibrillation, reinforcing the role of immune dysregulation in cardio-renal syndromes [24,136]. This evidence concerns the gene TNF and atrial fibrillation.